间充质基质细胞来源的细胞外囊泡通过miR-181a-5p-PTEN-pSTAT5-SOCS1轴重编程ARDS模型中的巨噬细胞
本研究探讨间充质基质细胞(MSC)来源的细胞外囊泡(EVs)在急性呼吸窘迫综合征(ARDS)中的免疫调节机制。体外实验使用LPS或ARDS患者血浆刺激的人单核细胞来源巨噬细胞(MDMs),体内实验使用LPS损伤的C57BL/6小鼠。结果表明,EVs通过传递miR-181a下调PTEN、激活pSTAT5并上调SOCS1,从而抑制巨噬细胞炎症因子分泌并减轻肺损伤。
要点
- MSC来源的EVs是抗炎调节的关键组分,其作用依赖于SOCS1。
- EVs中的miR-181a通过PTEN-pSTAT5-SOCS1轴重编程巨噬细胞。
- 在MSC中过表达miR-181a可增强EVs在ARDS模型中的疗效。
核心结论
- miR-181a-PTEN-pSTAT5-SOCS1轴是MSC EVs在ARDS中发挥免疫调节作用的新通路。
研究设计与样本
- 体外:人单核细胞来源巨噬细胞(MDMs)经LPS或ARDS患者血浆刺激,并给予MSC条件培养基或EVs处理。
- 体内:LPS损伤的C57BL/6小鼠接受来自miR-181a沉默或过表达MSC的EVs。
主要发现
- EVs显著减少LPS刺激或ARDS血浆刺激的MDMs分泌TNF-α和IL-8,且该作用依赖于SOCS1。
- EVs传递miR-181a下调PTEN,激活pSTAT5,上调巨噬细胞SOCS1。
- 体内EVs以miR-181a依赖的方式减轻肺损伤并上调肺泡巨噬细胞pSTAT5和SOCS1表达。
- 在MSC中过表达miR-181a显著增强EVs在该模型中的治疗疗效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE: A better understanding of the mechanism of action of mesenchymal stromal cells (MSCs) and their extracellular vesicles (EVs) is needed to support their use as novel therapies for acute respiratory distress syndrome (ARDS). Macrophages are important mediators of ARDS inflammatory response. Suppressor of cytokine signalling (SOCS) proteins are key regulators of the macrophage phenotype switch. We therefore investigated whether SOCS proteins are involved in mediation of the MSC effect on human macrophage reprogramming. METHODS: Human monocyte-derived macrophages (MDMs) were stimulated with lipopolysaccharide (LPS) or plasma samples from patients with ARDS (these samples were previously classified into hypo-inflammatory and hyper-inflammatory phenotype) and treated with MSC conditioned medium (CM) or EVs. Protein expression was measured by Western blot. EV micro RNA (miRNA) content was determined by miRNA sequencing. In vivo: LPS-injured C57BL/6 mice were given EVs isolated from MSCs in which miR-181a had been silenced by miRNA inhibitor or overexpressed using miRNA mimic. RESULTS: EVs were the key component of MSC CM responsible for anti-inflammatory modulation of human macrophages. EVs significantly reduced secretion of tumour necrosis factor-α and interleukin-8 by LPS-stimulated or ARDS plasma-stimulated MDMs and this was dependent on SOCS1. Transfer of miR-181a in EVs downregulated phosphatase and tensin homolog (PTEN) and subsequently activated phosphorylated signal transducer and activator of transcription 5 (pSTAT5) leading to upregulation of SOCS1 in macrophages. In vivo, EVs alleviated lung injury and upregulated pSTAT5 and SOCS1 expression in alveolar macrophages in a miR181-dependent manner. Overexpression of miR-181a in MSCs significantly enhanced therapeutic efficacy of EVs in this model. CONCLUSION: miR-181a-PTEN-pSTAT5-SOCS1 axis is a novel pathway responsible for immunomodulatory effect of MSC EVs in ARDS.
引用
- Su Y, Silva JD, Doherty D, et al. Mesenchymal stromal cells-derived extracellular vesicles reprogramme macrophages in ARDS models through the miR-181a-5p-PTEN-pSTAT5-SOCS1 axis. Thorax. 2022. PMID: 35948417. doi:10.1136/thoraxjnl-2021-218194
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。